Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
Public ClinicalTrials.gov record NCT03050151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To collect data on actual-use to assess technical performance and user injections of dupilumab auto-injection device by patients with atopic dermatitis (AD).
Study identification
- NCT ID
- NCT03050151
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 176 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2017 (Actual)
- Primary completion
- Nov 14, 2017 (Actual)
- Completion
- Feb 12, 2018 (Actual)
- Last update posted
- Aug 1, 2018
2017 – 2018
United States locations
- U.S. sites
- 37
- U.S. states
- 19
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Regeneron Investigational Site | Birmingham | Alabama | 35205 | — |
| Regeneron Investigational Site | Birmingham | Alabama | 35209 | — |
| Regeneron Investigational Site | Fort Smith | Arkansas | 72916 | — |
| Regeneron Investigational Site | Long Beach | California | 90808 | — |
| Regeneron Investigational Site | Los Angeles | California | 90025 | — |
| Regeneron Investigational Site | Murrieta | California | 92562 | — |
| Regeneron Investigational Site | Oceanside | California | 92056 | — |
| Regeneron Investigational Site | Orange | California | 92868 | — |
| Regeneron Investigational Site | Rolling Hills Estates | California | 90274 | — |
| Regeneron Investigational Site | Santa Monica | California | 90404 | — |
| Regeneron Investigational Site | Denver | Colorado | 80220 | — |
| Regeneron Investigational Site | Coral Gables | Florida | 33613 | — |
| Regeneron Investigational Site | Tampa | Florida | 33612 | — |
| Regeneron Investigational Site | Normal | Illinois | 61761 | — |
| Regeneron Investigational Site | Skokie | Illinois | 60077 | — |
| Regeneron Investigational Site | Indianapolis | Indiana | 46256 | — |
| Regeneron Investigational Site | Rockville | Maryland | 20850 | — |
| Regeneron Investigational Site | Plymouth | Minnesota | 55441 | — |
| Regeneron Investigational Site | Saint Joseph | Missouri | 64506 | — |
| Regeneron Investigational Site | Berlin | New Jersey | 08009 | — |
| Regeneron Investigational Site | Windsor | New Jersey | 08520 | — |
| Regeneron Investigational Site | Corning | New York | 14830 | — |
| Regeneron Investigational Site | Forest Hills | New York | 11375 | — |
| Regeneron Investigational Site | New York | New York | 10029 | — |
| Regeneron Investigational Site | High Point | North Carolina | 27262 | — |
| Regeneron Investigational Site | Raleigh | North Carolina | 27612 | — |
| Regeneron Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Regeneron Investigational Site | Portland | Oregon | 97223 | — |
| Regeneron Investigational Site | Charleston | South Carolina | 29420 | — |
| Regeneron Investigational Site | Greer | South Carolina | 29650 | — |
| Regeneron Investigational Site | Bellaire | Texas | 77401 | — |
| Regeneron Investigational Site | Fort Worth | Texas | 76244 | — |
| Regeneron Investigational Site | San Antonio | Texas | 78213 | — |
| Regeneron Investigational Site | San Antonio | Texas | 78218 | — |
| Regeneron Investigational Site | Webster | Texas | 77598 | — |
| Regeneron Investigational Site | Norfolk | Virginia | 23502 | — |
| Regeneron Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03050151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 1, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03050151 live on ClinicalTrials.gov.